• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    XOMA Corporation (XOMA)

    -NasdaqGM
    0.78 Down 0.05(6.10%) Sep 1, 4:00PM EDT
    |After Hours : 0.78 0.00 (0.00%) Sep 1, 5:10PM EDT
    Add to Portfolio
    Prev Close:0.83
    Open:0.83
    Bid:0.77 x 20000
    Ask:0.85 x 1000
    1y Target Est:4.17
    Beta:3.06558
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:0.78 - 0.84
    52wk Range:0.69 - 5.95
    Volume:1,499,392
    Avg Vol (3m):5,835,940
    Market Cap:92.52M
    P/E (ttm):N/A
    EPS (ttm):-0.71
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for XOMA

    Comparison

    Symbol% ChgMkt Cap
    XOMADown 6.10%92.52M
    REGNDown 3.33%52.45B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.64
    Quarterly EPS Est (Sep-15) :-0.16
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):-0.07

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback